Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will assess the Efficacy and Safety of different doses of PEG-rhG-CSF and a
single-dose of G-CSF in Preventing Chemotherapy-induced Neutropenia.
Phase:
Phase 2
Details
Lead Sponsor:
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Collaborators:
Beijing Cancer Hospital Cancer Institute and Hospital, Chinese Academy of Medical Sciences Changsha Central Hospital Jiangsu Cancer Institute & Hospital Second Affiliated Hospital, School of Medicine, Zhejiang University Shandong Cancer Hospital and Institute Subei People's Hospital of Jiangsu Province The Affiliated Hospital of Inner Mongolia Medical University The First Affiliated Hospital with Nanjing Medical University Wuhan TongJi Hospital Yangzhou No.1 People's Hospital